LDL cholesterol inhibits the breakdown of peripheral fat
The George Washington University has announced the establishment of the GW Institute for Nanotechnology. This institute will draw on the expertise of the University’s faculty members in mechanical, aerospace, electrical, computer, civil, and environmental engineering; physics, chemistry; and biochemistry. The institute is supported through special endowment funding designated for academic programs with the potential for
Full Post: A new Institute for Nanotechnology
The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet.
The discovery reveals a novel function of LDL as a regulator of fat turnover besides its well-established detrimental effects in promoting atherosclerosis.
The study, which is a collaboration of two research groups at Karolinska Institutet, is published in the open-access journal PLoS ONE . It shows that LDL cholesterol slows the rate of fat breakdown (i.e. lipolysis) in adipocytes, the peripheral cells responsible for fat storage. Previously, it has been known that release of free fatty acid from the peripheral fat to the blood stream increases the synthesis of LDL precursors in the liver.
“The results of our study provide evidence of a reciprocal link between the liver and peripheral fat regulating fat turnover”, says study-initiator Dr Johan Björkegren.
The discovery also opens up for new theories for the well-established association between blood lipids and the metabolic syndrome.
“If proven of general physiological importance, therapies lowering LDL, as for instances Statins, may also affect the turnover of peripheral fat,” continues Dr Björkegren.
The study and has been performed on cell cultures and tissues from humans as well as mouse models with different levels of LDL. The inhibitory effect was also shown to be dependent on LDL receptors on the surface of the fat cells.
“The exact intracellular mechanism for how the binding of LDL to the surface of the fat cells inhibits the breakdown of intracellular fat remains to be revealed”, say project leader Dr Josefin Skogsberg
A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor, which is responsible for removing the bad cholesterol (LDL-cholesterol) from the bloodstream, may be inhibited by a third protein,
Full Post: Major discovery in the control of bad cholesterol
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes. The growth of fat cells and their metabolism
Full Post: Control of blood vessels a possible weapon against obesity
Mice that were fed a diet rich in fat, sugar and cholesterol for nine months developed a preliminary stage of the morbid irregularities that form in the brains of Alzheimer’s patients. The study results, published in a doctoral thesis from the Swedish medical university Karolinska Institutet (KI), give some indications of how this difficult to
Full Post: Diet rich in fat, sugar and cholesterol a potential risk factor for Alzheimer’s disease
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users. There is accumulating evidence that the effect statins can have on skeletal muscle - including muscle weakness, fatigue and deterioration - is underestimated, said Jill Slade, assistant professor of radiology and osteopathic manipulative medicine
Full Post: Do statins cause muscle problems?
An international research team has identified 11 novel locations in the human genome where common variations appear to influence cholesterol or triglyceride levels, bringing the total number of lipid-associated genes to 30. While major mutations in some of these genes have been known to underlie rare lipid metabolism disorders, it is becoming apparent that common
Full Post: Discovery of 11 new gene sites that influence cholesterol or triglyceride levels